Sunshine Biopharma, Inc. (SBFM)
1.12
-0.05
(-4.27%)
USD |
NASDAQ |
Sep 03, 16:00
1.13
+0.01
(+0.89%)
After-Hours: 19:06
Sunshine Biopharma Total Assets (Quarterly) : 33.63M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.63M |
| March 31, 2026 | 27.93M |
| December 31, 2025 | 30.08M |
| September 30, 2025 | 31.49M |
| June 30, 2025 | 31.97M |
| March 31, 2025 | 29.19M |
| December 31, 2024 | 30.56M |
| September 30, 2024 | 30.06M |
| June 30, 2024 | 29.30M |
| March 31, 2024 | 31.90M |
| December 31, 2023 | 27.35M |
| September 30, 2023 | 27.65M |
| June 30, 2023 | 28.41M |
| March 31, 2023 | 26.99M |
| December 31, 2022 | 29.55M |
| September 30, 2022 | 40.86M |
| June 30, 2022 | 41.99M |
| March 31, 2022 | 13.41M |
| December 31, 2021 | 2.203M |
| September 30, 2021 | 2.502M |
| June 30, 2021 | 1.817M |
| March 31, 2021 | 1.858M |
| December 31, 2020 | 1.046M |
| September 30, 2020 | 0.5505M |
| June 30, 2020 | 0.1385M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0637M |
| December 31, 2019 | 0.0981M |
| September 30, 2019 | 0.1463M |
| June 30, 2019 | 0.1094M |
| March 31, 2019 | 1.247M |
| December 31, 2018 | 1.147M |
| September 30, 2018 | 1.104M |
| June 30, 2018 | 1.170M |
| March 31, 2018 | 1.002M |
| December 31, 2017 | 0.2575M |
| September 30, 2017 | 0.256M |
| June 30, 2017 | 0.1643M |
| March 31, 2017 | 0.0234M |
| December 31, 2016 | 0.0644M |
| September 30, 2016 | 0.5993M |
| June 30, 2016 | 0.6654M |
| March 31, 2016 | 0.8306M |
| December 31, 2015 | 0.6733M |
| September 30, 2015 | 0.1366M |
| June 30, 2015 | 0.1707M |
| March 31, 2015 | 0.1487M |
| December 31, 2014 | 0.1434M |
| September 30, 2014 | 0.1803M |
| June 30, 2014 | 0.0441M |
| March 31, 2014 | 0.0718M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.095M |
| Shareholders Equity (Quarterly) | 27.54M |
| Debt to Equity Ratio | 0.0246 |
| Current Ratio | 5.457 |
| Net Debt Paydown Yield | 1.03% |